Takahashi Satoru

高橋智 | Takahashi Satoru

Affiliation and department：
Homepage URL (1)： http://www.med.nagoya-cu.ac.jp/patho1.dir/

Research field (4)： Molecular biology , Human pathology , Tumor biology , Experimental pathology

Research keywords (3)：実験病理 , 化学予防 , 前立腺癌

Research theme for competitive and other funds (10)：

2022 - 2025 MicroRNAに着目した去勢抵抗性前立腺癌の予防法とバイオマーカーの探求
2019 - 2023 去勢抵抗性前立腺癌に対する新規免疫療法の確立に目指した腫瘍免疫機構の解明
2019 - 2022 Interaction between hepatocytes and stellate cells in NASH
2017 - 2020 Molecular mechanisms for prostate cancer prevention induced by natural flavonoid
2016 - 2019 Molecular analysis of therapeutic effects of angiotensin II type I receptor blocker against castration resistant prostate cancer

Show all

Papers (393)：

Yasuki Hori, Itaru Naitoh, Aya Naiki-Ito, Tatsuya Kawai, Michihiro Yoshida, Akihisa Kato, Kenta Kachi, Hidenori Sahashi, Akihisa Adachi, Tadashi Toyohara, et al. Incidence of Pancreatic Injury and Pancreatitis in Patients Treated With Immune Checkpoint Inhibitors. Clinical and translational gastroenterology. 2024. 15. 4. e00667
Konomu Uno, Takaya Shimura, Shingo Inaguma, Keita Kuroyanagi, Ruriko Nishigaki, Takuya Kanno, Makiko Sasaki, Shigeki Fukusada, Naomi Sugimura, Yusuke Mizuno, et al. Clinical impact of proton pump inhibitor and potassium-competitive acid blocker for predicting the curability of endoscopic resection in ulcerative early gastric cancer. Digestion. 2024
Sunao Ito, Akira Koshino, Masayuki Komura, Shunsuke Kato, Takahiro Otani, Chengbo Wang, Akane Ueki, Hiroki Takahashi, Masahide Ebi, Naotaka Ogasawara, et al. Characterization of colorectal cancer by hierarchical clustering analyses of five immune cell markers. Pathology International. 2023
Hayato Ota, Hirokazu Sato, Shuji Mizumoto, Ken Wakai, Kei Yoneda, Kazuo Yamamoto, Hayao Nakanishi, Jun-Ichiro Ikeda, Shinichi Sakamoto, Tomohiko Ichikawa, et al. Switching mechanism from AR to EGFR signaling via 3-O-sulfated heparan sulfate in castration-resistant prostate cancer. Scientific reports. 2023. 13. 1. 11618-11618
Akiko Kato, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Tomoka Hisada, Yasuaki Uemoto, Mitsuo Terada, Hiroyuki Kato, Masayuki Komura, et al. Low TINAGL1 expression is a marker for poor prognosis in breast cancer. Journal of cancer research and clinical oncology. 2023. 149. 8. 4771-4782

ｍore...

MISC (112)：

伊藤直, 稲熊真悟, 小川了, 小村理行, 加藤寛之, 内木綾, 齋藤正樹, 上野修平, 早川俊輔, 大久保友貴, et al. 膵癌におけるテトラスパニンCD63の発現と臨床的意義. 日本外科学会定期学術集会抄録集. 2023. 123回. SF-1
Taku Naiki, Aya Naiki-Ito, Hiroyuki Kato, Keitaro Iida, Toshiki Etani, Yuko Nagayasu, Shugo Suzuki, Yoriko Yamashita, Takahiro Yasui, Satoru Takahashi. MIR-8080 RECRUITMENT INHIBITS EXPRESSION OF ANDROGEN RECEPTOR SPLICING VARIANTS IN CASTRATION-RESISTANT PROSTATE CANCER. JOURNAL OF UROLOGY. 2020. 203. E218-E218
Taku Naiki, Aya Naiki-Ito, Toshiki Etani, Keitaro Iida, Ryosuke Ando, Takashi Nagai, Noriyasu Kawai, Satoru Takahashi, Takahiro Yasui. GPX2 PROMOTES THE DEVELOPMENT OF BLADDER CANCER WITH SQUAMOUS DIFFERENTIATION THROUGH APOPTOSIS CONTROL. JOURNAL OF UROLOGY. 2020. 203. E4-E4
Naiki, Taku, Naiki-Ito, Aya, Etani, Toshiki, Iida, Keitaro, Ando, Ryosuke, Nagai, Takashi, Kawai, Noriyasu, Takahashi, Satoru, Yasui, Takahiro. LUTEOLIN SUPPRESSES ANDROGEN RECEPTOR SPLICE VARIANT 7 EXPRESSION VIA MIRNA RECRUITMENT IN CASTRATION-RESISTANT PROSTATE CANCER. JOURNAL OF UROLOGY. 2019. 201. 4. E1175-E1175
Iida, Keitaro, Naiki, Taku, Naiki-Ito, Aya, Etani, Toshiki, Ando, Ryosuke, Kawai, Noriyasu, Takahashi, Satoru, Yasui, Takahiro. Therapeutic effects of the natural flavonoid "Luteolin" on bladder cancer. CANCER SCIENCE. 2018. 109. 966-966

ｍore...

Education (2)：

- 1991 Nagoya City University Graduate School of Medical Sciences
- 1987 Nagoya City University Medical School

Professional career (1)：

名古屋市立大学大学院医学研究科/博士(医学)

Committee career (3)：

独立行政法人医薬品医療機器総合機構GLP評価委員会委員
内閣府食品安全委員会・化学物質・汚染物質専門調査会委員
内閣府食品安全委員会・食品添加物専門調査会委員

Association Membership(s) (6)：

アメリカ癌学会 , 日本がん予防学会 , 日本臨床細胞学会 , 日本毒性病理学会 , 日本病理学会 , 日本癌学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page